AMGEN Message Board - Msg: 42216

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMGEN

AMGN 296.30

-0.7%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nathan L. who wrote ()	3/23/1996 8:09:00 AM
From: Craig Slotoroff	of 42

Hi Nathan. I follow Amgen, got in at 45 and again at 47 and have been holding ever since. I love the companies pipline of drugs, and see nothing both growth for this company. Did you hear the news on Friday that a companey (I think Immune something) got the rights to what they think is the receptor (binding site) of lepton to the cell. Some researchers thing that since all people have lepton in their bodies, obese people may have a mutated or faulty lepton receptor. They think that it may be the receptor that needs to be targeted in order for obese people to lose the lbs. Any info or ideas you have are greatly appreciated. Craig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next